Replies to post #116962 on Biotech Values

[DewDiligence]

Jury rules for ABT in Norvir antitrust case:

http://finance.yahoo.com/news/US-jury-rejects-Glaxo-rb-3617576509.html?x=0&.v=1

As noted in the prologue of #msg-61329210, I thought GSK’s argument in this case was bogus.